| Nov 21, 2025 |
Nov 25, 2025 |
Acrivon Therapeutics, Inc.
|
CEO |
Sell |
48.8
|
-19,904
|
-0.84%
|
✗
|
$45.8K |
| Nov 14, 2025 |
Nov 18, 2025 |
Acrivon Therapeutics, Inc.
|
CEO |
Sell |
42.5
|
-60,255
|
-2.47%
|
✗
|
$135K |
| Aug 21, 2025 |
Aug 25, 2025 |
Acrivon Therapeutics, Inc.
|
CEO |
Sell |
48.8
|
-19,905
|
-0.81%
|
✗
|
$26.3K |
| Aug 14, 2025 |
Aug 18, 2025 |
Acrivon Therapeutics, Inc.
|
CEO |
Sell |
42.5
|
-60,256
|
-2.39%
|
✗
|
$83.8K |
| May 21, 2025 |
May 23, 2025 |
Acrivon Therapeutics, Inc.
|
CEO |
Sell |
48.8
|
-19,904
|
-0.78%
|
✗
|
$22.9K |
| May 14, 2025 |
May 16, 2025 |
Acrivon Therapeutics, Inc.
|
CEO |
Sell |
42.5
|
-60,257
|
-2.32%
|
✗
|
$68.7K |
| Feb 21, 2025 |
Feb 25, 2025 |
Acrivon Therapeutics, Inc.
|
CEO |
Sell |
45.0
|
-19,904
|
-0.76%
|
✗
|
$110.3K |
| Feb 14, 2025 |
Feb 19, 2025 |
Acrivon Therapeutics, Inc.
|
CEO |
Sell |
42.5
|
-37,731
|
-1.42%
|
✗
|
$204.5K |
| Nov 21, 2024 |
Nov 25, 2024 |
Acrivon Therapeutics, Inc.
|
CEO |
Sell |
45.0
|
-19,910
|
-0.74%
|
✗
|
$128.2K |
| Nov 14, 2024 |
Nov 18, 2024 |
Acrivon Therapeutics, Inc.
|
CEO |
Sell |
40.0
|
-60,256
|
-2.20%
|
✗
|
$477.2K |
| Aug 21, 2024 |
Aug 23, 2024 |
Acrivon Therapeutics, Inc.
|
CEO |
Sell |
40.0
|
-79,616
|
-2.82%
|
✗
|
$731.7K |
| Aug 14, 2024 |
Aug 16, 2024 |
Acrivon Therapeutics, Inc.
|
CEO |
Sell |
40.0
|
-59,765
|
-2.08%
|
✗
|
$419.6K |
| May 14, 2024 |
May 16, 2024 |
Acrivon Therapeutics, Inc.
|
CEO |
Sell |
40.0
|
-54,918
|
-1.87%
|
✗
|
$459.1K |
| Feb 14, 2024 |
Feb 16, 2024 |
Acrivon Therapeutics, Inc.
|
CEO |
Sell |
42.5
|
-41,861
|
-1.41%
|
✗
|
$142.3K |
| Nov 14, 2023 |
Nov 16, 2023 |
Acrivon Therapeutics, Inc.
|
CEO |
Sell |
37.5
|
-239,023
|
-7.43%
|
✗
|
$1.2M |